The dopamine transporter: Relevance to attention deficit hyperactivity disorder (ADHD)

Behavioural Brain Research

Volumn 130, Issue 1-2, 2002, Pages 57-63

  Madras, Bertha K ^a   Miller, Gregory M ^a   Fischman, Alan J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Altropane; Attention deficit hyperactivity disorder; Dopamine; Monoamine transporters; Polymorphisms; SPECT imaging

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER;

ATTENTION DEFICIT DISORDER; CONFERENCE PAPER; CORPUS STRIATUM; DIAGNOSTIC TEST; DOPAMINE BRAIN LEVEL; GENE TRANSFER; GENETIC POLYMORPHISM; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERTROPHY; NERVE ENDING; NONHUMAN; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; REGULATORY MECHANISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS;

EID: 0037051168     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00439-9     Document Type: Conference Paper

References (84)

1. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
2. High-resolution brain SPECT imaging in ADHD
3. High resolution brain SPECT imaging of marijuana smokers with AD/HD
4. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder
5. Cerebellum in attention-deficit hyperactivity disorder: A morphometric MRI study
6. Attention-deficit/hyperactivity disorder: A life-span perspective
7. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder
8. Toward a pathophysiology of attention-deficit/hyperactivity disorder
9. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse
10. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1
11. Association of attention-deficit disorder and the dopamine transporter gene
12. Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas
13. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples
14. [(3)H]PNU-18, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain
15. Dopamine transporter density in patients with attention deficit hyperactivity disorder
16. Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
17. 18F]DOPA accumulation in children with attention deficit hyperactivity disorder
18. Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects
19. Neurobiology of attention-deficit hyperactivity disorder
20. Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters
21. 11C-WIN 35, 428 reveals marked declines in mild Parkinson's disease
22. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))
23. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia
24. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
25. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
26. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
27. Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD)
28. Genotype influences in vivo dopamine transporter availability in human striatum
29. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease
30. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
31. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
32. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode
33. 123I]beta-CIT
34. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine
35. Prediction of dopamine transporter binding availability by genotype: A preliminary report
36. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3)
37. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum
38. 11C]tetrabenazine and positron emission tomography
39. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder
40. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
41. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
42. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
43. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease
44. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
45. Neurometrics, dynamic brain imaging and attention deficit hyperactivity disorder
46. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain
47. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain
48. Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain
49. 123I] beta-CIT SPECT
50. 123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
51. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans
52. 11C]WIN-35, 428
53. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: No association found
54. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome
55. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: Implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders
56. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression
57. Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations
58. Dopamine transporter binding in Gilles de la Tourette syndrome
59. Human dopamine transporter gene polymorphism (VNTR) and alcoholism
60. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study
61. Lack of association between dopamine transporter gene polymorphisms and delusional disorder
62. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia
63. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse
64. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene
65. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms
66. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder
67. Anti-hyperactivity medication: Methylphenidate and amphetamine
68. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome
69. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder
70. Attention-deficit/hyperactivity disorder and comorbidity
71. 123)I]-beta-CIT SPECt-study
72. Novelty seeking and a dopamine transporter gene polymorphism (DAT1)
73. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention
74. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach
75. The dopamine receptor DRD4 gene: Are duplications distracting
76. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
77. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders
78. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain
79. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
80. Cocaine uptake is decreased in the brain of detoxified cocaine abusers
81. Association and linkage of the dopamine transporter gene and attention- deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity
82. Brain dopamine transporter in spontaneously hypertensive rats
83. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo
84. Brain metabolism in teenagers with attention-deficit hyperactivity disorder